Hence, our novel findings regarding the functions of GPC-1 in managing the intrinsic and extrinsic CAF phenotypes of BSCs in prostate cancer are important as they suggest GPC-1 as a novel anti-CAF target in prostate cancer. This evidence concerns the gene GPC1 and prostate carcinoma.